
Publication
Essential Corporate News – Week ending 23 May 2025
The Companies and Limited Liability Partnerships (Annotation) Regulations 2025 and an accompanying Explanatory Memorandum were published on 14 May 2025.
United States | Publication | November 2022
On October 21, 2022, the US Department of Health and Human Services, along with the FBI and the Cybersecurity Infrastructure and Security Agency (CISA), issued a bulletin warning that a cyber threat actor group known as "Daixin Team," is actively targeting US businesses, predominantly in the healthcare and public health sectors, with ransomware and data extortion operations. The bulletin contains several technical recommendations that should be passed along and, if possible, implemented by your IT teams.
But cybersecurity begins at the top of an organization, a point the Federal Trade Commission (FTC) emphasized in a proposed consent issued on October 24. In that matter, the FTC alleged that a company's failure to use appropriate information security practices was the responsibility of the CEO. The FTC alleged that the CEO did not implement, or properly delegate responsibility to implement, reasonable information security practices, by failing to hire an executive responsible for information security—although he hired executives for many other areas. In the proposed consent, that individual, for the next 10 years, will be responsible for ensuring that any future company where he is a majority owner or CEO (or similar position) has implemented and maintains a comprehensive information security program.
If you have questions about implementing your security program or conducting ongoing risk assessments, please contact the Norton Rose Fulbright professionals listed below.
Publication
The Companies and Limited Liability Partnerships (Annotation) Regulations 2025 and an accompanying Explanatory Memorandum were published on 14 May 2025.
Publication
In a recent decision, Matco Tools Corporation v. Canada (Attorney General), the Federal Court has overturned a Commissioner of Patents (the Commissioner) decision regarding a patent applicant failing to meet the “due care” standard in the context of an unpaid maintenance fee.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025